These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 24853387)

  • 1. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
    Deng L; Cornett BL; Mackie K; Hohmann AG
    Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
    Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG
    Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse.
    Lin X; Xu Z; Carey L; Romero J; Makriyannis A; Hillard CJ; Ruggiero E; Dockum M; Houk G; Mackie K; Albrecht PJ; Rice FL; Hohmann AG
    Pain; 2022 May; 163(5):834-851. PubMed ID: 35001054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally administered cannabinoid receptor 2 (CB
    Wilkerson JL; Alberti LB; Thakur GA; Makriyannis A; Milligan ED
    Brain Res; 2022 Jan; 1774():147721. PubMed ID: 34774500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy.
    Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J
    J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
    La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
    Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Biomed Pharmacother; 2024 Jul; 176():116879. PubMed ID: 38850666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects.
    Rahn EJ; Thakur GA; Wood JA; Zvonok AM; Makriyannis A; Hohmann AG
    Pharmacol Biochem Behav; 2011 Jun; 98(4):493-502. PubMed ID: 21382397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain.
    Wilkerson JL; Alberti LB; Kerwin AA; Ledent CA; Thakur GA; Makriyannis A; Milligan ED
    Brain Behav; 2020 Dec; 10(12):e01850. PubMed ID: 32977358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
    Curry ZA; Wilkerson JL; Bagdas D; Kyte SL; Patel N; Donvito G; Mustafa MA; Poklis JL; Niphakis MJ; Hsu KL; Cravatt BF; Gewirtz DA; Damaj MI; Lichtman AH
    J Pharmacol Exp Ther; 2018 Jul; 366(1):169-183. PubMed ID: 29540562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.